Company / R&D per Share
Equillium, Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.05
FY2025
5-year range
$0.90 / $1.09
FY2022-FY2025
Trend
+0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1.09 to $1.05 over the past 2 years.
Based on SEC 10-K filings.
1.05 in FY2025 with a 3-year CAGR of +5.5%.
Declined from $1.09 to $1.05 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +5.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 0.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.05 | +0.2% |
| FY2024 | $1.05 | -3.7% |
| FY2023 | $1.09 | +21.8% |
| FY2022 | $0.90 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026